Viewing Study NCT00549718


Ignite Creation Date: 2025-12-25 @ 4:30 AM
Ignite Modification Date: 2026-02-23 @ 7:59 PM
Study NCT ID: NCT00549718
Status: COMPLETED
Last Update Posted: 2014-06-11
First Post: 2007-10-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia
Sponsor: Sumitomo Pharma America, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Schizophrenia View
None SM-13496 View
None Latuda View
None Lurasidone View